Compounds > cyc 202
Page last updated: 2024-09-04

cyc 202 and panobinostat

cyc 202 has been researched along with panobinostat in 1 studies

Compound Research Comparison

Studies
(cyc 202)		Trials
(cyc 202)		Recent Studies (post-2010)
(cyc 202)		Studies
(panobinostat)		Trials
(panobinostat)		Recent Studies (post-2010) (panobinostat)
979739367895593

Protein Interaction Comparison

ProteinTaxonomycyc 202 (IC50)panobinostat (IC50)
Histone deacetylase 8Schistosoma mansoni0.45
Histone deacetylase 3Homo sapiens (human)0.2031
Bromodomain-containing protein 4Homo sapiens (human)0.005
Cytochrome P450 3A5Homo sapiens (human)0.0033
Histone deacetylase 4Homo sapiens (human)0.3792
Histone deacetylase 1Homo sapiens (human)0.181
Histone deacetylase 7Homo sapiens (human)0.9434
Histone deacetylase 2Homo sapiens (human)0.2527
Polyamine deacetylase HDAC10Homo sapiens (human)0.007
Histone deacetylase 11 Homo sapiens (human)0.8396
Histone deacetylase 8Homo sapiens (human)0.46
Histone deacetylase 6Homo sapiens (human)0.2307
Histone deacetylase 9Homo sapiens (human)0.5825
Histone deacetylase 5Homo sapiens (human)0.3424
Histone deacetylase Plasmodium falciparum (malaria parasite P. falciparum)0.0025
Nuclear receptor corepressor 2Homo sapiens (human)0.002

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dan, Y; Gan, L; Gan, Z; Jiang, J; Li, W; Pan, T; Ran, D; Tang, Q; Yu, Y; Zhang, L1

Other Studies

1 other study(ies) available for cyc 202 and panobinostat

ArticleYear
Discovery of novel 9H-purin derivatives as dual inhibitors of HDAC1 and CDK2.
    Bioorganic & medicinal chemistry letters, 2019, 08-15, Volume: 29, Issue:16

    Topics: Drug Design; Histone Deacetylase Inhibitors; Humans; Molecular Structure; Structure-Activity Relationship

2019